News & Events

dyconex_logo_25years
12.05.2016

DYCONEX celebrates its 25th anniversary

DYCONEX AG, an MST company and the world's leading provider of highly complex solutions in the area of interconnect technology, will celebrate its 25th anniversary in September 2016.

MST at IMAPS Technology Workshop Lyon 2016 - France

IMAPS
Microelectronics, Systems & Packaging
December 7 - 8, 2016
Metropole Hotel, Lyon, France

MST at MD&M West Anaheim 2017

MD&M West

Medical Design & Manufacturing
February 7 - 9, 2017
Convention Center Anaheim, CA, USA
Hall E, Booth# 510


DYCONEX LIQUID CRYSTAL POLYMER (LCP) SUBSTRATE PROVES CYTOTOXICITY CONFORMITY ACCORDING TO ISO 10993-5

Cytotoxicity, a standardized test for materials used in medical devices, is used to determine if significant quantities of harmful extractable substances are present and how these may negatively affect cellular components. Harlan Cytotest Cell Research GmbH recently performed a cytotoxicity test on an LCP product manufactured by DYCONEX and certified in an official declaration the non-cytotoxicity of the product and it's suitability for in-vitro application.

Due to its biocompatibility, hermeticity properties, chemical inertness and advantageous electromechanical properties, LCP circuit boards are especially well-suited for biomedical and temporary implantable applications.